Cardiovascular Systems, Inc. (NASDAQ:CSII) Scheduled to Post Earnings on Tuesday
Cardiovascular Systems, Inc. (NASDAQ:CSII) will release its earnings data after the market closes on Tuesday, August 1st. Analysts expect Cardiovascular Systems to post earnings of ($0.05) per share for the quarter. Cardiovascular Systems has set its Q4 guidance at ($0.06)-($0.04) EPS.
Cardiovascular Systems (NASDAQ:CSII) last announced its quarterly earnings data on Wednesday, May 3rd. The medical device company reported ($0.05) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.05). Cardiovascular Systems had a negative net margin of 3.72% and a negative return on equity of 4.36%. The company had revenue of $52.10 million for the quarter, compared to the consensus estimate of $51.13 million. During the same period in the prior year, the firm posted ($0.31) EPS. The company’s quarterly revenue was up 17.1% compared to the same quarter last year. On average, analysts expect Cardiovascular Systems to post $-0.13 EPS for the current fiscal year and $0.04 EPS for the next fiscal year.
Shares of Cardiovascular Systems, Inc. (NASDAQ CSII) opened at 32.41 on Tuesday. The firm has a 50 day moving average of $31.70 and a 200-day moving average of $29.04. The stock’s market capitalization is $1.06 billion. Cardiovascular Systems, Inc. has a 12 month low of $18.82 and a 12 month high of $33.11.
COPYRIGHT VIOLATION NOTICE: “Cardiovascular Systems, Inc. (NASDAQ:CSII) Scheduled to Post Earnings on Tuesday” was first published by American Banking News and is the property of of American Banking News. If you are accessing this story on another site, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/07/25/cardiovascular-systems-inc-nasdaqcsii-scheduled-to-post-earnings-on-tuesday.html.
A number of research analysts have recently commented on the stock. Needham & Company LLC reissued a “buy” rating and set a $37.00 target price (up from $32.00) on shares of Cardiovascular Systems in a research report on Friday, July 14th. TheStreet raised shares of Cardiovascular Systems from a “d” rating to a “c-” rating in a research report on Thursday, May 4th. BidaskClub cut shares of Cardiovascular Systems from a “buy” rating to a “hold” rating in a research report on Thursday, July 13th. Finally, Bank of America Corporation cut shares of Cardiovascular Systems from a “neutral” rating to an “underperform” rating in a research report on Wednesday, June 21st. One analyst has rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $33.83.
About Cardiovascular Systems
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Receive News & Ratings for Cardiovascular Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.